stomach pain retatrutide Where to Inject Retatrutide: A Doctor's Simple Guide Retatrutide Significantly Reduces Visceral Fat

All clinical trial protocols used once-weekly subcutaneous injection

However, GLP-1 regulates lipid metabolism by enhancing the function of BAT or promoting WAT browning

The trial data are available at PubMed (PMID: 37530551), providing peer-reviewed evidence for the retatrutide weight-loss results

Tips for Managing Nausea in Patients The most common side effect a patient may experience when they first start Saxenda is nausea

[1] [2] This weekly dosing schedule is consistent with other long-acting incretin-based therapies and is designed to maintain stable plasma drug concentrations throughout the week, minimising peaks and troughs that could exacerbate side effects